In announcing new autism prevalence data from the Centers for Disease Control and Prevention, Health and Human Services ...

Replimune Group, Inc.'s RP1 + OPDIVO for advanced melanoma gains FDA Priority Review. PDUFA date: July 22, 2025. Read more on ...

University of Miami Miller School of Medicine researchers have identified molecular evidence linking human papillomavirus ...